Manufacturers Life Insurance Company, The Vertex Pharmaceuticals Inc Transaction History
Manufacturers Life Insurance Company, The
- $100 Billion
- Q1 2025
A detailed history of Manufacturers Life Insurance Company, The transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 546,904 shares of VRTX stock, worth $238 Million. This represents 0.26% of its overall portfolio holdings.
Number of Shares
546,904
Previous 545,366
0.28%
Holding current value
$238 Million
Previous $220 Million
20.73%
% of portfolio
0.26%
Previous 0.2%
Shares
35 transactions
Others Institutions Holding VRTX
# of Institutions
1,830Shares Held
233MCall Options Held
1.38MPut Options Held
1.08M-
Capital World Investors Los Angeles, CA28.5MShares$12.4 Billion2.34% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.5MShares$10.2 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$9.29 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.5MShares$6.34 Billion1.6% of portfolio
-
State Street Corp Boston, MA11.8MShares$5.14 Billion0.24% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $112B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...